Profile
NTRB VRTX VRNA REGN ALNY ARGX
Company Name Nutriband Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $77.34M $108.04B $72.68B $67.32B $58.93B $50.86B
Employees 0.01K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO Gareth Sheridan Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
NTRB VRTX VRNA REGN ALNY ARGX
Quant Rating Score 1 3 1 4 2 4
Quant Rating Strong Sell Neutral Strong Sell Buy Sell Buy
Trading
NTRB VRTX VRNA REGN ALNY ARGX
Last Close $5.53 $416.25 $106.91 $646.87 $440.49 $851.015
High 52 $10.72 $516.74 $106.91 $828.42 $491.09 $851.75
Low 52 $3.85 $366.54 $35.37 $482.92 $224.58 $532.27
Price vs. 52 Week High -48.41 % -19.45 % 0 % -21.92 % -10.3 % -0.09 %
Price vs. 52 Week Low 43.64 % 13.56 % 202.26 % 33.95 % 96.14 % 59.88 %
Total Return
NTRB VRTX VRNA REGN ALNY ARGX
1 Month Return -28.92 % 1.49 % 0 % 10.91 % -4.15 % 6.73 %
3 Month Return -22.11 % 10.81 % 1.43 % 15.55 % 1.19 % 26.57 %
6 Month Return -4.33 % -4.27 % 54.7 % 15.3 % 59.24 % 36.61 %
9 Month Return -29.45 % -11.31 % 77.41 % -8.83 % 59.49 % 31.61 %
YTD Return 17.41 % 3.36 % 130.21 % -9.19 % 87.2 % 38.38 %
1 Year Return -0.54 % -17.16 % 180.02 % -21.54 % 61.81 % 43.89 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NTRB VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.41 % - -
Dividend Paid and Capex Coverage Ration (TTM) -117.68 % 11.09 % -147.93 % 4.25 % 5.97 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
NTRB VRTX VRNA REGN ALNY ARGX
Asset Growth -0.63 % 53.91 %
Gross Profit Growth -18.88 % 5941.02 %
Revenue Growth 2.62 % -
Revenue 3 Year 12.54 % -23.33 %
Revenue 5 Year 244.45 % 290254.46 %
Revenue 10 Year - -
EBIT Growth -93.38 % -162.64 %
Net Income Growth -91.11 % -218.96 %
Net Income 3 Yeari Growth Per Share 6.91 % -126.38 %
Net Income 5 Yeari Growth Per Share -123.75 % 33.14 %
Net Income 10 Yeari Growth Per Share -1496465.12 % -7.28 %
Operating Income Growth -37.32 % -127.96 %
Operating Cash Flow Growth (CFG) -31.17 % -143.33 %
Operating 3 Year CFG -23.18 % -166.57 %
Operating 5 Year CFG -208.61 % 55.51 %
Operating 10 Year CFG - 41.1 %
EPS Growth -43.48 % -200 %
EPS Diluted Growth -43.48 % -215.05 %
Book Value Per Share -25.12 % -24.01 %
Share Holder 3 Year Equity Growth Per Share -59.46 % 0.26 %
Share Holder 5 Year Equity Growth Per Share 2086.26 % -25.62 %
Share Holder 10 Year Equity Growth Per Share 32107.37 % -72.3 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share -100 % -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -22.77 % 139.05 %
Free Cash Flow Growth -31.84 % -144.48 %
Updated On 31 Jan 2025 31 Dec 2024
Profitability
NTRB VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM 33.15 % 86.11 % 95.15 % 85.39 % 51.22 % 65.82 %
Return on Assets TTM -100.9 % 15.13 % -14.17 % 11.4 % 0.9 % 15.06 %
Return on Equity TTM -131.4 % 22.14 % -38.66 % 15.31 % 26.13 % 18.96 %
Return on Capital Employed TTM -79.11 % 19.72 % -10.74 % 10.32 % 8.03 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 111.3 % 88.98 % -136.38 % 237.3 %
EBT Per Ebit TTM 150.84 % 111.48 % 130.22 % 139.5 % -12.07 % 147.38 %
EBIT Per Revenue TTM -264.04 % 34.36 % -25.27 % 25.89 % 8.25 % 13.47 %
Cash Flow To Debt Ratio TTM -2196.54 % 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Receivables Turnover TTM 16.03 6.03 2.55 2.51 3.33 1.91
Payables Turnover TTM 1.24 3.59 3.13 2.3 2.69 0.9
Inventory Turnover TTM 12.49 1.06 1.25 0.64 4.2 2.26
Fixed Asset Turnover TTM 365.24 % 431.08 % 8642.22 % 284.82 % 463.12 % 5009.77 %
Asset Turnover TTM 25.33 % 47.51 % 38.7 % 35.47 % 66.16 % 31.97 %
Operating Cash Flow Per Share TTM -0.44 14.98 -0.85 48.94 2.02 5.67
Free Cash Flow Per Share TTM -0.44 13.63 -0.85 40.09 1.68 5.58
Cash Per Share TTM 62.35 % 2486.48 % 511.44 % 8148.65 % 2072.79 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -190.05 % 33.68 % -32.7 % 35.59 % 8.28 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.85 % 90.99 % 100.75 % 81.92 % 83.26 % 98.47 %
Cash Flow Coverage Ratios TTM -2196.54 % 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Price To Free Cash Flows Ratio TTM -15.65 30.87 -995.27 16.2 266.2 127.08
Price To Operating Cash Flows Ratio TTM -15.87 28.12 -126.33 13.32 222.27 145.15
Price Cash Flow Ratio TTM -15.87 28.12 -126.33 13.32 222.27 145.15
Income Statement (TTM)
NTRB VRTX VRNA REGN ALNY ARGX
Revenue $0B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 32.68% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.01B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -0.99 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
NTRB VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $2.59B $0.03B
Total Liabilities $0B $6.12B $0.27B $8.41B $4.23B $0.7B
Total Equity $0.01B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0B $6.65B $0.02B $15.42B $1.8B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $2.74B $0.04B
Total Assets $0.01B $22.53B $0.47B $37.76B $4.3B $6.2B
Cash Flow Statement (TTM)
NTRB VRTX VRNA REGN ALNY ARGX
Net Income $-0.01B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $-0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 31.4
AARD Aardvark Therapeutics, Inc. Common Stock 10.025
ABCL AbCellera Biologics Inc. 3.635
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.085
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.775
ABPWW 0.0173
ABSI Absci Corporation 3.245
ABUS Arbutus Biopharma Corporation 4.38
ABVC ABVC BioPharma, Inc. 2.805
ABVX Abivax SA American Depositary Shares 102.86
ACAD ACADIA Pharmaceuticals Inc. 21.98
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.638
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.4586
ACIU AC Immune SA 3.265
ETFs With Exposure to NTRB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00004 325.2
VXF Vanguard Extended Market Index Fund 0.00043 203.135
IWC iShares Micro-Cap ETF 0 145.72
VTSAX Vanguard Total Stock Market Index Fund 0.00004 160.27
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00043 156.17
VITSX Vanguard Total Stock Market Index Fund 0.00004 160.3
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00043 156.18
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 509.14
VEMPX Vanguard Extended Market Index InstlPlus 0.00043 385.39
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00004 300.71
Unlock